Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 98
of 5Next
1:

Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs.

Larrat S, Hilleret MN, Germi R, Lupo J, Nicod S, Zarski JP, Seigneurin JM, Morand P.

Comp Hepatol. 2008 Mar 12;7:3.

PMID: 18336716 [PubMed - in process]

2:

In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.

Qi X, Xiong S, Yang H, Miller M, Delaney WE 4th.

Antivir Ther. 2007;12(3):355-62.

PMID: 17591025 [PubMed - indexed for MEDLINE]

3:

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, Chung YH, Lee YS, Yoo W, Kim SO.

Hepatology. 2006 Jun;43(6):1385-91.

PMID: 16729316 [PubMed - indexed for MEDLINE]

4:

Adefovir dipivoxil: a review of its use in chronic hepatitis B.

Dando T, Plosker G.

Drugs. 2003;63(20):2215-34. Review.

PMID: 14498759 [PubMed - indexed for MEDLINE]

6:

Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.

Villet S, Pichoud C, Villeneuve JP, Trépo C, Zoulim F.

Gastroenterology. 2006 Oct;131(4):1253-61. Epub 2006 Aug 16.

PMID: 17030194 [PubMed - indexed for MEDLINE]

7:

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

PMID: 16904047 [PubMed - indexed for MEDLINE]

8:

Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.

Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WE 4th, Gerin JL, Tennant BC.

Antiviral Res. 2004 Aug;63(2):115-21.

PMID: 15302140 [PubMed - indexed for MEDLINE]

9:

Adefovir dipivoxil alone or in combination with lamivudine for three months in patients with lamivudine resistant compensated chronic hepatitis B.

Akyildiz M, Gunsar F, Ersoz G, Karasu Z, Ilter T, Batur Y, Akarca U.

Dig Dis Sci. 2007 Dec;52(12):3444-7. Epub 2007 Apr 12.

PMID: 17431777 [PubMed - indexed for MEDLINE]

10:

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

van Bömmel F, Zöllner B, Sarrazin C, Spengler U, Hüppe D, Möller B, Feucht HH, Wiedenmann B, Berg T.

Hepatology. 2006 Aug;44(2):318-25.

PMID: 16871563 [PubMed - indexed for MEDLINE]

11:

Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B.

van der Poorten D, Prakoso E, Khoo TL, Ngu MC, McCaughan GW, Strasser SI, Lee AU.

J Gastroenterol Hepatol. 2007 Sep;22(9):1500-5. Epub 2007 Aug 6.

PMID: 17683493 [PubMed - indexed for MEDLINE]

12:

Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients.

Westland CE, Yang H, Delaney WE 4th, Wulfsohn M, Lama N, Gibbs CS, Miller MD, Fry J, Brosgart CL, Schiff ER, Xiong S.

J Viral Hepat. 2005 Jan;12(1):67-73.

PMID: 15655050 [PubMed - indexed for MEDLINE]

13:

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

Peters MG, Hann Hw H, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df D, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL.

Gastroenterology. 2004 Jan;126(1):91-101.

PMID: 14699491 [PubMed - indexed for MEDLINE]

14:

Treatment of chronic hepatitis B: case selection and duration of therapy.

Leung N.

J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.

PMID: 11982721 [PubMed - indexed for MEDLINE]

15:

Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil.

Chen CH, Wang JH, Lee CM, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS.

Antivir Ther. 2006;11(6):771-8.

PMID: 17310821 [PubMed - indexed for MEDLINE]

16:

Management of viral hepatitis B.

Pramoolsinsup C.

J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.

PMID: 12000599 [PubMed - indexed for MEDLINE]

17:

Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant.

Ratziu V, Thibault V, Benhamou Y, Poynard T.

Comp Hepatol. 2006 Jan 11;5:1.

PMID: 16405720 [PubMed]

18:

Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

Lampertico P, Viganò M, Manenti E, Iavarone M, Sablon E, Colombo M.

Gastroenterology. 2007 Nov;133(5):1445-51. Epub 2007 Sep 2.

PMID: 17983801 [PubMed - indexed for MEDLINE]

19:

Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.

Wiegand J, Tischendorf JJ, Nashan B, Klempnauer J, Flemming P, Niemann P, Rohde P, Manns MP, Trautwein C, Tillmann HL.

Z Gastroenterol. 2004 Jan;42(1):15-8.

PMID: 14997399 [PubMed - indexed for MEDLINE]

20:

Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.

Dai CY, Chuang WL, Hsieh MY, Lee LP, Huang JF, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.

Antiviral Res. 2007 Aug;75(2):146-51. Epub 2007 Mar 16.

PMID: 17400303 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 98
of 5Next